Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | MI130004 |
Synonyms | |
Therapy Description |
MI130004 is an antibody-drug conjugate that consists of PM050489 and trastuzumab, which interferes with the microtubule network, potentially leading to cell death and antitumor activity (PMID: 29440297). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MI130004 | MI130004 is an antibody-drug conjugate that consists of PM050489 and trastuzumab, which interferes with the microtubule network, potentially leading to cell death and antitumor activity (PMID: 29440297). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|